Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Should It Stay or Should It Go: Managing Medications at End of Life (TH138)
Ist Teil von
Journal of pain and symptom management, 2022-05, Vol.63 (5), p.792-792
Ort / Verlag
Madison: Elsevier Inc
Erscheinungsjahr
2022
Quelle
Applied Social Sciences Index & Abstracts (ASSIA)
Beschreibungen/Notizen
Outcomes
1. Demonstrate an understanding of how medications contribute to symptoms at end of life
2. Recognize the pharmacokinetic and pharmacodynamic challenges at end of life
3. Follow a systematic approach to deprescribing
This interactive case-based session will focus on medication management for patients receiving hospice care. There are many challenges caring for complex patients receiving multiple medications. It is important to distinguish between symptoms secondary to disease progression and symptoms related to adverse drug reactions. Reducing risk of agitated delirium at end of life includes thoughtful deprescribing. A systematic approach to stopping unnecessary and potentially harmful medications will be discussed, as well as a practical discussion of pharmacokinetics and pharmacodynamics at end of life.